Fiche centre
Parkwood Institute
London — Canada
Essais liés4clinical trials
VilleLondonlocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04619420
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| JNJ-63733657 | Alzheimer | Phase 2 | NCT04619420 | Autonomy — A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease | TERMINATED |
| Neuraceq | Alzheimer | À vérifier | NCT05617014 | ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4 | ENROLLING_BY_INVITATION |
| Perindopril | Alzheimer | Phase 2 | NCT02085265 | Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients | TERMINATED |
| The Ontario Neurodegenerative Disease Research Initiative | Sclérose latérale amyotrophique | À vérifier | NCT04104373 | The Ontario Neurodegenerative Disease Research Initiative | COMPLETED |